Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print

Financial Report: ICON



By Kristin Brooks



Published February 20, 2014
ICON
 
4Q Revenues: $345 million (+15%)

4Q Earnings: $33.5 million (+62%)

FY Revenues: $1.34 billion (+20%)

FY Earnings: $102.8 million (+86%)

Comments: Operating income was $38.7 million or 11% of revenue in the quarter, and net business awards were $446 million representing a book to bill of 1.29. For the year operating income before non-recurring charges was $130.2 million or 10% of revenue, and net new business awards were $1.6 billion, representing a book to bill of 1.23. Backlog increased 12% for the year to $3.1 billion.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On